GB1082624A - Improvements in or relating to therapeutically active compounds - Google Patents

Improvements in or relating to therapeutically active compounds

Info

Publication number
GB1082624A
GB1082624A GB836565A GB836565A GB1082624A GB 1082624 A GB1082624 A GB 1082624A GB 836565 A GB836565 A GB 836565A GB 836565 A GB836565 A GB 836565A GB 1082624 A GB1082624 A GB 1082624A
Authority
GB
United Kingdom
Prior art keywords
linolenic acid
relating
active compounds
therapeutically active
acid itself
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB836565A
Inventor
James O'hara
John Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calmic Ltd
Original Assignee
Calmic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calmic Ltd filed Critical Calmic Ltd
Priority to GB836565A priority Critical patent/GB1082624A/en
Publication of GB1082624A publication Critical patent/GB1082624A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)

Abstract

A pharmaceutical preparation for the treatment of vascular, particularly cardiovascular, diseases comprises an oil extracted from the seeds of Oenothera biennis L. (evening primrose), g -linolenic acid itself or a functional derivative thereof (e.g. a glyceride, methyl or ethyl ester) and an acceptable pharmaceutical vehicle therefor. The oil extract contains the triglyceride of g -linolenic acid and g -linolenic acid itself and also the methyl ester of linoleic acid. The preparations are in the form of dosage units and administration may be orally (e.g. tablets, coated tablets, capsules, cachets, powders, granules, syrup or elixir) or parenterally (e.g. sterile liquid solution, suspension or emulsion).
GB836565A 1965-02-26 1965-02-26 Improvements in or relating to therapeutically active compounds Expired GB1082624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB836565A GB1082624A (en) 1965-02-26 1965-02-26 Improvements in or relating to therapeutically active compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB836565A GB1082624A (en) 1965-02-26 1965-02-26 Improvements in or relating to therapeutically active compounds
FR51211A FR5413M (en) 1965-02-26 1966-02-25

Publications (1)

Publication Number Publication Date
GB1082624A true GB1082624A (en) 1967-09-06

Family

ID=9851148

Family Applications (1)

Application Number Title Priority Date Filing Date
GB836565A Expired GB1082624A (en) 1965-02-26 1965-02-26 Improvements in or relating to therapeutically active compounds

Country Status (2)

Country Link
FR (1) FR5413M (en)
GB (1) GB1082624A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097602A (en) * 1974-11-29 1978-06-27 Silver Melvin J Method of inhibiting blood platelet aggregation
EP0019423A1 (en) * 1979-05-18 1980-11-26 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0035856A2 (en) * 1980-03-07 1981-09-16 Efamol Limited Pharmaceutical and dietary compositions
EP0087863A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical and dietary composition
EP0093516A1 (en) * 1982-04-29 1983-11-09 Efamol Limited Pharmaceutical composition
EP0132089A1 (en) * 1983-07-14 1985-01-23 Scotia Holdings Plc Fatty acid compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
EP0173478A1 (en) * 1984-08-15 1986-03-05 Scotia Holdings Plc Treatment of skin disorders
EP0181689A1 (en) * 1984-10-03 1986-05-21 Efamol Limited Use of copper and fatty acids
FR2588187A1 (en) * 1985-10-07 1987-04-10 Rochas Parfums New cosmetic or dermatological compositions rich in essential fatty acids present both in the form of triglycerides and in the free or salified form
US4938984A (en) * 1982-04-16 1990-07-03 Nestec S. A. Nutritive compositions containing fatty substances
US4999380A (en) * 1988-10-18 1991-03-12 Nestec S.A. Treatment of lipoprotein disorders associated with cholesterol metabolism
EP0440341A1 (en) 1990-01-18 1991-08-07 Scotia Holdings Plc EFA compositions and therapy
US5120760A (en) * 1988-06-10 1992-06-09 Efamol Holdings Plc Treating tardive dyskinesia with essential fatty acid compositions
US5234952A (en) * 1988-12-23 1993-08-10 Nestec S.A. Reduction of thrombogenicity with lipids of blackcurrant seed
US5324748A (en) * 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
FR2714573A1 (en) * 1993-12-31 1995-07-07 Inst Rech Biolog Sa Use of currant seed oils to produce dietary supplements
EP0748590A1 (en) * 1995-06-15 1996-12-18 Institut De Recherche Biologique Oil-bearing product based feed supplement and fabrication process

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097602A (en) * 1974-11-29 1978-06-27 Silver Melvin J Method of inhibiting blood platelet aggregation
EP0019423A1 (en) * 1979-05-18 1980-11-26 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
EP0035856A2 (en) * 1980-03-07 1981-09-16 Efamol Limited Pharmaceutical and dietary compositions
EP0035856A3 (en) * 1980-03-07 1981-09-23 Efamol Limited Pharmaceutical and dietary compositions
EP0078434A1 (en) * 1980-03-07 1983-05-11 Efamol Limited Pharmaceutical and dietary compositions
US5324748A (en) * 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
EP0087863A2 (en) * 1982-03-01 1983-09-07 Efamol Limited Pharmaceutical and dietary composition
EP0087863A3 (en) * 1982-03-01 1984-03-21 Efamol Limited Pharmaceutical and dietary composition
US4938984A (en) * 1982-04-16 1990-07-03 Nestec S. A. Nutritive compositions containing fatty substances
US4970235A (en) * 1982-04-16 1990-11-13 Nestec S.A. Medicaments containing of linolenic acid
EP0093516A1 (en) * 1982-04-29 1983-11-09 Efamol Limited Pharmaceutical composition
EP0132089A1 (en) * 1983-07-14 1985-01-23 Scotia Holdings Plc Fatty acid compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
EP0173478A1 (en) * 1984-08-15 1986-03-05 Scotia Holdings Plc Treatment of skin disorders
US4965075A (en) * 1984-10-03 1990-10-23 Efamol Limited Methods of increasing 1-series PGs in the body
EP0181689A1 (en) * 1984-10-03 1986-05-21 Efamol Limited Use of copper and fatty acids
FR2588187A1 (en) * 1985-10-07 1987-04-10 Rochas Parfums New cosmetic or dermatological compositions rich in essential fatty acids present both in the form of triglycerides and in the free or salified form
US5120760A (en) * 1988-06-10 1992-06-09 Efamol Holdings Plc Treating tardive dyskinesia with essential fatty acid compositions
US4999380A (en) * 1988-10-18 1991-03-12 Nestec S.A. Treatment of lipoprotein disorders associated with cholesterol metabolism
US5234952A (en) * 1988-12-23 1993-08-10 Nestec S.A. Reduction of thrombogenicity with lipids of blackcurrant seed
EP0440341A1 (en) 1990-01-18 1991-08-07 Scotia Holdings Plc EFA compositions and therapy
FR2714573A1 (en) * 1993-12-31 1995-07-07 Inst Rech Biolog Sa Use of currant seed oils to produce dietary supplements
EP0748590A1 (en) * 1995-06-15 1996-12-18 Institut De Recherche Biologique Oil-bearing product based feed supplement and fabrication process

Also Published As

Publication number Publication date
FR5413M (en) 1967-10-02

Similar Documents

Publication Publication Date Title
Li et al. Health-promoting effects of the citrus flavanone hesperidin
Asgarpanah et al. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L.
US4309415A (en) Method and composition for treating inflammatory disorders
US20150196577A1 (en) Compounds, Compositions and Methods for Protecting Brain Health in Neurodegenerative Disorders
US4666701A (en) Pharmaceutical and dietary compositions
US5198468A (en) Essential fatty acid composition
US4758592A (en) Method of treating or preventing endometriosis
Kashiwada et al. Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids
Prajapati et al. Phytochemical and pharmacological review of Lagenaria sicereria
AU2003232248B8 (en) Formulations useful in the treatment of male and female impotence
US5958417A (en) Herbal combinations
ES2240995T3 (en) Time-dependent release capsules containing omega-3 polinsaturated acids for the treatment of the inflammatory disease of the intestine.
Mohammad Nabavi et al. Neuroprotective effects of ginkgolide B against ischemic stroke: A review of current literature
RU2671208C2 (en) Compositions containing 15-ohepa and methods of using same
Al-Naqeep et al. Antiatherogenic potential of Nigella sativa seeds and oil in diet-induced hypercholesterolemia in rabbits
US7084122B2 (en) Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
JP2893460B2 (en) Fatty acid treatments and compositions
US20110280852A1 (en) Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
US4842859A (en) Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
Pandey et al. Traditional uses, phytochemistry and pharmacological properties of Neolamarckia cadamba: a review
MA Domingues et al. Bioactive triterpenic acids: from agroforestry biomass residues to promising therapeutic tools
Chen et al. Bioactivity‐guided isolation of antiosteoporotic compounds from Ligustrum lucidum
GB1040544A (en) Improvements in or relating to therapeutic compounds and the manufacture thereof
US5945106A (en) Montoxic extract of Larrea tridentata and method of making the same
Kashyap et al. Ursolic acid and oleanolic acid: pentacyclic terpenoids with promising anti-inflammatory activities